Related Experiment Video

Updated: Mar 29, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma

Jufeng Zhang1, Daping Wang2, Jianyi Xiong2

  • 1Department of Biological Sciences, School of Life Science, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China ; Department of Orthopaedics, Shenzhen Second People's Hospital, Shenzhen, Guangdong 518039, P.R. China ; Shenzhen Key Laboratory for Tissue Engineering, Shenzhen, Guangdong 518039, P.R. China.

Oncology Letters
|December 2, 2015
PubMed

Insights

MicroRNAs (miRNAs) play roles in cancer. This study found miR-33a-5p is downregulated in osteosarcoma (OS) and inhibits OS cell growth, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in various human cancers.
  • Aberrant miRNA expression is observed in osteosarcoma (OS).
  • The specific roles of miRNAs in OS pathogenesis are not fully elucidated.

Purpose of the Study:

  • To identify deregulated microRNAs (miRNAs) in osteosarcoma (OS).
  • To investigate the functional role of miR-33a-5p in OS.
  • To explore the potential of miR-33a-5p as a diagnostic and therapeutic target for OS.

Main Methods:

  • High-throughput deep sequencing to screen for differentially expressed miRNAs in OS tissues.
  • TaqMan reverse transcription-polymerase chain reaction (RT-PCR) to validate miRNA expression.
  • In vitro cell culture and transfection assays to assess the functional impact of miR-33a-5p.

Main Results:

  • Screening identified 310 overexpressed and 41 downregulated miRNAs in OS samples.
  • miR-33a-5p was significantly downregulated in OS tissues compared to non-tumor controls.
  • Restoring miR-33a-5p levels inhibited OS cell proliferation, indicating tumor-suppressive activity.

Conclusions:

  • miR-33a-5p acts as a tumor suppressor in osteosarcoma.
  • Downregulation of miR-33a-5p is a significant finding in OS.
  • miR-33a-5p holds promise as a potential biomarker and therapeutic agent for osteosarcoma.
Keywords:
microRNA-33a-5posteosarcomatumor suppressor gene

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K
Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

87

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K